top of page

University of Strathclyde and Brightwake Limited: Innovative Diagnostic Tool for Blood Cell Chemistry

The collaboration between the University of Strathclyde and Brightwake Limited aims to develop an innovative diagnostic capability for quantifying blood cell chemistry at the point of care. This tool will enable healthcare providers to quickly and accurately assess blood cell chemistry, leading to better patient outcomes and more efficient care.

Feedback Overview:

The idea of developing an innovative diagnostic tool for quantifying blood cell chemistry at the point of care is highly promising. This tool addresses a critical need for rapid and accurate diagnostics in healthcare settings, which can significantly improve patient outcomes and streamline care processes. To enhance the product-market fit, consider conducting extensive market research to understand the specific needs of healthcare providers and patients. Additionally, ensure that the tool is user-friendly and integrates seamlessly with existing healthcare systems.

Market Competitors:

Market Competitor

Market Competitor

Market Competitor

Market Competitor

Market Competitor

Market Competitor

Chief Medical Officer (CMO)

Medical diagnostics and patient care

How will this diagnostic tool improve patient outcomes compared to existing methods?

The tool provides rapid and accurate analysis of blood cell chemistry at the point of care, allowing for timely and informed treatment decisions, which can lead to better patient outcomes.

What are the potential challenges in integrating this tool into current healthcare systems?

Potential challenges include ensuring compatibility with existing electronic health records (EHR) systems, training healthcare providers to use the new tool, and obtaining regulatory approvals.

What are the key features that healthcare providers are looking for in a point of care diagnostic tool?

Healthcare providers prioritize accuracy, speed, ease of use, and the ability to provide actionable insights that can directly influence patient care decisions.

bottom of page